Filippi J F, Nicolino-Brunet C, Tubiana N, Carcassonne Y, Sampol J
Laboratoire d'Hématologie Biologique, Faculté de Médecine et de Pharmacie, Marseille, France.
Pathol Biol (Paris). 1991 Jan;39(1):47-9.
Chronic lymphocytic leukemia B-cells (B-CLL cells) have surface immunoglobulin (Smlg). In addition, cytoplasmic immunoglobulins (Clg) have been reported in chronic lymphocytic leukemia B-cells and are useful for ascertaining monoclonality of the disease. In a study of 60 cases of chronic lymphocytic leukemia B-cells, surface immunoglobulin determinations alone demonstrated monoclonality in 38% of cases, versus 65% of cases with combined surface immunoglobulin and cytoplasmic immunoglobulins determinations. Membrane markers were studied using a panel of monoclonal antibodies. Thirty-six per cent of patients were positive for CD 10. No correlations were seen between immunologic markers and clinical stage.
慢性淋巴细胞白血病B细胞(B-CLL细胞)具有表面免疫球蛋白(Smlg)。此外,在慢性淋巴细胞白血病B细胞中已报道有细胞质免疫球蛋白(Clg),其有助于确定该疾病的单克隆性。在一项对60例慢性淋巴细胞白血病B细胞的研究中,仅进行表面免疫球蛋白测定时,38%的病例显示为单克隆性,而同时进行表面免疫球蛋白和细胞质免疫球蛋白测定时,这一比例为65%。使用一组单克隆抗体研究膜标志物。36%的患者CD10呈阳性。未发现免疫标志物与临床分期之间存在相关性。